Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-07-31
1988-07-05
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544266, 544267, 544272, C07D23936, A61K 3152
Patent
active
047555173
ABSTRACT:
The present invention is a novel disubstituted derivative of xanthine, pharmaceutical composition and method of use therefor. Activity of the novel xanthine includes particularly cognition activation.
REFERENCES:
patent: 3624215 (1971-11-01), Steden
patent: 3624216 (1971-11-01), Steden
patent: 4031218 (1977-06-01), El-Antably
patent: 4089959 (1978-05-01), Dianund
patent: 4233303 (1980-11-01), Bergstrand et al.
patent: 4364962 (1980-12-01), Berne et al.
patent: 4452788 (1984-06-01), Bristol et al.
patent: 4469698 (1984-09-01), Philipossian
patent: 4593095 (1986-06-01), Snyder et al.
Pharmcol. (1985) 330:212-221.
J. Med. Chem. (1985) 28:1334-1340.
J. Med. Chem. (1985) 28:1071-1079.
J. Med. Chem. (1985) 28:487-492.
Proceedings of the Federation of American Society for Experimental Biology, vol. 45, No. 4, 3/5/86 (Abst.).
Jerry March Textbook, "Advanced Organic Chemistry, Reactions, Mechanisms, and Structures", p. 42 from Chapter 2.
Bruns Robert F.
Hamilton Harriet W.
Rizzo Nicholas S.
Thierstein Joan
Warner-Lambert & Company
LandOfFree
Derivatives of xanthine, pharmaceutical compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of xanthine, pharmaceutical compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of xanthine, pharmaceutical compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2332552